Point72 Asset Management
DGX icon

Point72 Asset Management’s Quest Diagnostics DGX Stock Holding History

Point72 Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-41,600
Closed -$5.85M – 2544
2023
Q2 		$5.85M Buy
41,600
+40,000
+2,500% +$5.51M 0.02% 762
2023
Q1 		$226K Buy
+1,600
New +$229K ﹤0.01% 1447

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Point72 Asset Management's DGX Position: Q1 2026 in Review

Point72 Asset Management sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 100,301 shares — an estimated $17.4M sold.

Point72 Asset Management first reported a position in DGX in Q2 2014 and held it in 13 quarters. The position peaked at $137M in Q2 2023. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Point72 Asset Management reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 100,301 Quest Diagnostics shares in Q1 2026, an estimated $17.4M.
  • Point72 Asset Management first reported a position in Quest Diagnostics in Q2 2014 and held it in 13 quarters.
  • Point72 Asset Management's Quest Diagnostics position peaked at $137M in Q2 2023.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.